Evidence map›Paper›PMID 33525321›Full record

ReviewMetabolites2021

Propolis from the Monte Region in Argentina: A Potential Phytotherapic and Food Functional Ingredient.

Iris Catiana Zampini, Ana Lia Salas, Luis M Maldonado, Mario J Simirgiotis, María Inés Isla

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Iris Catiana ZampiniInstituto de Bioprospección y Fisiología Vegetal (INBIOFIV, CONICET-UNT), San Miguel de Tucumán 4000, Argentina.ORCID 0000-0001-7941-1678
Ana Lia SalasInstituto de Bioprospección y Fisiología Vegetal (INBIOFIV, CONICET-UNT), San Miguel de Tucumán 4000, Argentina.
Luis M MaldonadoInstituto Nacional de Tecnología Agropecuaria (INTA), Estación Experimental Agropecuaria Famaillá, Ruta Provincial 301-km 32, Famaillá, San Miguel de Tucumán 4000, Argentina.
Mario J SimirgiotisInstituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Valdivia 5090000, Chile.
María Inés IslaInstituto de Bioprospección y Fisiología Vegetal (INBIOFIV, CONICET-UNT), San Miguel de Tucumán 4000, Argentina.
National University of Tucumán · ARAustral University of Chile · CLNational Agricultural Technology Institute · AR

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT 2017 Number 4436Consejo Nacional de Investigaciones Científicas y Técnicas CONICET, PUE 2018- 0011Fondo Nacional de Desarrollo Científico y Tecnológico FONDECYT 1180059Universidad Nacional de Tucumán PIUNT G 637
6 · The paper itself

Abstract

The aim of this review is to provide overall information on Argentine propolis and to shed light on its potential, especially the one from the Monte region so as to support future research in the field. Around 1999, the Argentine propolis began to be chemically and functionally characterized to give it greater added value. Because Argentina has a wide plant biodiversity, it is expected that its propolis will have various botanical origins, and consequently, a different chemical composition. To date, five types have been defined. Based on their functionality, several products have been developed for use in human and veterinary medicine and in animal and human food. Because the Argentine propolis with the greatest potential is that of the Monte eco-region, this review will describe the findings of the last 20 years on this propolis, its botanical source (

Indexed as

antimicrobial and nematicidalArgentine propolischalconesfree radical scavenging activitymetabolic syndromeZuccagnia punctata

Identifiers

PMID33525321
PMCPMC7911552
OpenAlexW3128031368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.